76360-43-5

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 2-bromothiophene-3-carboxylate is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new therapeutic agents. Its unique structure allows for the creation of compounds with potential medicinal properties.
Used in Agrochemical Industry:
In the agrochemical sector, Methyl 2-bromothiophene-3-carboxylate is utilized as an intermediate in the production of various agrochemicals, including pesticides and herbicides, due to its reactive functional groups that can be tailored for specific applications in agriculture.
Used in Organic Chemistry Research:
Methyl 2-bromothiophene-3-carboxylate is employed as a versatile building block in organic chemistry research, enabling the synthesis of a wide array of organic compounds with diverse applications, from materials science to specialty chemicals.
Used in Fine Chemicals Production:
Methyl 2-bromothiophene-3-carboxylate is used as a starting material in the production of fine chemicals, which are high-purity chemicals used in various industries, including pharmaceuticals, fragrances, and flavors, due to its potential to form complex molecular structures with specific properties.

Upstream product

• 186581-53-3 diazomethane 
• 24287-95-4 2-bromothiophene-3-carboxylic acid 
• 498-62-4 3-thiophene carboxaldehyde 
• 74-88-4 methyl iodide 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 67-56-1 methanol 
• 88-13-1 3-Thiophene carboxylic acid 
• 197370-13-1 2-bromo-3-thiophene carboxylic acid chloride 
• 89280-91-1 2,5-dibromothiophene-3-carboxylic acid methyl ester 

Downstream Products

• 859492-59-4 (+/-)-2-(2-methyl-6-nitro-phenyl)-thiophene-3-carboxylic acid 
• 1254709-94-8 methyl 2-(4-fluoro-3-methylphenyl)thiophene-3-carboxylate 
• 1254709-93-7 methyl 2-(3-methyl-4-nitrophenyl)thiophene-3-carboxylate 
• 1395044-64-0 C₅₂H₇₀O₆S₄ 
• 1395044-63-9 C₂₀H₁₆Br₂O₆S₂ 
• 1395044-62-8 C₂₀H₁₈O₆S₂ 
• 1384579-71-8 7-iodo-6-phenyl-4H-thieno[3,2-c]pyran-4-one 
• 1295502-12-3 5H-dithieno[3,2-b:2',3'-d]pyran-5-one 
• 4751-59-1 5,6,7,8-tetrahydro-4H-thieno[3,2-c]azepine-4-one 
• 1009827-27-3 4-oxo-4,5-dihydrothieno[3,2-c]quinoline-7-carbonitrile 

Relevant academic research and scientific papers

PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS

Compounds of the formula (I) wherein the substituents are as defined in claim 1. Furthermore, the present invention relates to agrochemical compositions which comprise compounds of formula (I), to preparation of these compositions, and to the use of the compounds or compositions in agriculture or horticulture for combating, preventing or controlling animal pests, including arthropods and in particular insects, moluscs, nematodes or representatives of the order Acarina.

An attempt to synthesize a terthienyl-based analog of indacenedithiophene (IDT): unexpected synthesis of a naphtho[2,3-b]thiophene derivative

We report herein our attempt to synthesize an analog of indacenedithiophene (IDT) based on a tetraphenylhexyl substituted, covalently bridgedsyn-terthienyl unit. Instead of the expected compound the adopted synthetic route led to the formation of an unexpected, new naphtho[2,3-b]thiophene derivative. The structure of this compound was fully characterized by NMR and HRMS as well as single crystal X-ray diffraction and its electronic properties have been analyzed by UV-vis absorption spectroscopy and cyclic voltammetry. A possible mechanism for the formation of this compound is also proposed on the basis of detailed theoretical investigations.

HISTONE ACETYLTRANSFERASE (HAT) INHIBITOR AND USE THEREOF

The present invention relates to a histone acetyltransferase (HAT) inhibitor. Provided are a compound represented by general formula I, a pharmaceutically acceptable salt, a stereoisomer, an enantiomer, a diastereomer, an atropisomer, a racemate, a polymorph, a solvate or an isotope-labeled compound (including deuterium substitution) thereof, a preparation method therefor, a pharmaceutical composition comprising the same, and use thereof in the treatment of various HAT-related diseases or conditions.

p-diaminobenzene derivative as potassium channel regulator, preparation method and medical applications thereof

The invention relates to a p-diaminobenzene derivative as a potassium channel regulator, a preparation method and medical applications thereof, and specifically discloses a compound represented by a general formula A or a pharmaceutically acceptable salt

ERK INHIBITORS

The present invention provides thieno[2,3-c]pyrrol-4-one compounds that inhibit activity of extracellular-signal-regulated kinase (ERK) and may be useful in the treatment of cancer.

PIPERIDINE ISOXAZOLE AND ISOTHIAZOLE OREXIN RECEPTOR ANTAGONISTS

The present invention is directed to piperidine isoxazole and isothiazole orexin compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

6,5-BICYCLIC OCTAHYDROPYRROLOPYRIDINE OREXIN RECEPTOR ANTAGONISTS

The present invention is directed to 6,5-bicyclic octahydropyrrolopyridine compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.

PIPERIDINE OXADIAZOLE AND THIADIAZOLE OREXIN RECEPTOR ANTAGONISTS

The present invention is directed to piperidine oxadiazole and thiadiazole orexin compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

ERK INHIBITORS

The present invention provides thieno[2,3-c]pyrrol-4-one compounds that inhibit activity of extracellular-signal-regulated kinase (ERK) and may be useful in the treatment of cancer.

ETHYLDIAMINE OREXIN RECEPTOR ANTAGONISTS

The present invention is directed to ethyldiamne compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.